These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 25924452)

  • 1. [Early human papillomavirus testing predicts residual/recurrent disease after LEEP risk factors for predicting residual disease in high-grade squamous cervical intraepithelial neoplasia following LEEP conization].
    Niu XY; Feng YK
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):321-5. PubMed ID: 25924452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions.
    Baloglu A; Uysal D; Bezircioglu I; Bicer M; Inci A
    Arch Gynecol Obstet; 2010 Jul; 282(1):69-73. PubMed ID: 19940997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3.
    Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Campo E; Pahisa J; Ordi J
    Gynecol Oncol; 2006 Nov; 103(2):631-6. PubMed ID: 16780934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early human papillomavirus testing predicts residual/recurrent disease after LEEP.
    Ryu A; Nam K; Kwak J; Kim J; Jeon S
    J Gynecol Oncol; 2012 Oct; 23(4):217-25. PubMed ID: 23094124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia.
    Sarian LO; Derchain SF; Andrade LA; Tambascia J; Morais SS; Syrjänen KJ
    Gynecol Oncol; 2004 Jul; 94(1):181-6. PubMed ID: 15262139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-risk human papillomavirus testing for monitoring patients treated for high-grade cervical intraepithelial neoplasia.
    Jeong NH; Lee NW; Kim HJ; Kim T; Lee KW
    J Obstet Gynaecol Res; 2009 Aug; 35(4):706-11. PubMed ID: 19751331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of cervical intraepithelial neoplasia (CIN) with colposcopic biopsy and efficacy of loop electrosurgical excision procedure (LEEP).
    Duesing N; Schwarz J; Choschzick M; Jaenicke F; Gieseking F; Issa R; Mahner S; Woelber L
    Arch Gynecol Obstet; 2012 Dec; 286(6):1549-54. PubMed ID: 22865036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pap Smear Combined with HPV Testing: A Reasonable Tool for Women with High-grade Cervical Intraepithelial Neoplasia Treated by LEEP.
    Mo LZ; Song HL; Wang JL; He Q; Qiu ZC; Li F
    Asian Pac J Cancer Prev; 2015; 16(10):4297-302. PubMed ID: 26028089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation.
    Heymans J; Benoy IH; Poppe W; Depuydt CE
    Int J Cancer; 2011 Aug; 129(4):903-9. PubMed ID: 21064091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus combined with cytology and margin status identifies patients at risk for recurrence after conization for high-grade cervical intraepithelial neoplasia.
    Ruano Y; Torrents M; Ferrer FJ
    Eur J Gynaecol Oncol; 2015; 36(3):245-51. PubMed ID: 26189247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus genotyping as a reliable prognostic marker of recurrence after loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia (CIN2-3) especially in postmenopausal women.
    Kang WD; Kim SM
    Menopause; 2016 Jan; 23(1):81-6. PubMed ID: 26057824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of human papillomavirus testing in the follow-up of patients with high-grade cervical intraepithelial neoplasia after conization.
    Chao A; Lin CT; Hsueh S; Chou HH; Chang TC; Chen MY; Lai CH
    Am J Obstet Gynecol; 2004 Apr; 190(4):1046-51. PubMed ID: 15118639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical performance of hybrid capture 2 human papillomavirus testing for recurrent high-grade cervical/vaginal intraepithelial neoplasm in patients with an ASC-US Papanicolaou test result during long-term posttherapy follow-up monitoring.
    De Vivar AD; Dawlett M; Wang JP; Jack A; Gong Y; Staerkel G; Guo M
    Arch Pathol Lab Med; 2015 Feb; 139(2):219-24. PubMed ID: 25611104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of residual/recurrent disease by HPV genotype after loop excision procedure for high-grade cervical intraepithelial neoplasia with negative margins.
    Wu D; Zheng Y; Chen W; Guo C; Yu J; Chen G; Huang Y
    Aust N Z J Obstet Gynaecol; 2011 Apr; 51(2):114-8. PubMed ID: 21466511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-treatment human papillomavirus status and recurrence rates in patients treated with loop electrosurgical excision procedure conization for cervical intraepithelial neoplasia.
    Du R; Meng W; Chen ZF; Zhang Y; Chen SY; Ding Y
    Eur J Gynaecol Oncol; 2013; 34(6):548-51. PubMed ID: 24601049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of human papillomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelial lesions.
    Houfflin Debarge V; Collinet P; Vinatier D; Ego A; Dewilde A; Boman F; Leroy JL
    Gynecol Oncol; 2003 Sep; 90(3):587-92. PubMed ID: 13678729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical outcome and high risk factor for residual lesion analysis of HSIL half a year after loop electrosurgical excision procedure: a clinical study of 1 502 cases].
    Liu L; Chen LM; Tao X; Dai F; Guo LP; Zhang HW; Zhou XR; Sui L
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):751-756. PubMed ID: 29179270
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation of recurrence rates and times with posttreatment human papillomavirus status in patients treated with loop electrosurgical excision procedure conization for cervical squamous intraepithelial lesions.
    Prato B; Ghelardi A; Gadducci A; Marchetti I; Di Cristofano C; Di Coscio G; Bevilacqua G; Genazzani AR
    Int J Gynecol Cancer; 2008; 18(1):90-4. PubMed ID: 17506849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of endocervical margin and high-risk human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, and microinvasive carcinoma of the uterine cervix.
    Kong TW; Son JH; Chang SJ; Paek J; Lee Y; Ryu HS
    Gynecol Oncol; 2014 Dec; 135(3):468-73. PubMed ID: 25284039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'See and treat' regime by LEEP conisation is a safe and time saving procedure among women with cytological high-grade squamous intraepithelial lesion.
    Kjellberg L; Tavelin B
    Acta Obstet Gynecol Scand; 2007; 86(9):1140-4. PubMed ID: 17712659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.